Humana Inc (NYSE:HUM) stock fell as much as 7.5% before trimming losses to 4% following a court ruling against the health insurer in its Medicare bonus payment lawsuit. The decision also impacted ...

Goldman Sachs stock rises 20% YTD, outpacing the S&P 500. Analysts suggest holding GS due to its high momentum but caution on ...

A federal judge has ordered long-term care pharmacy company Omnicare to pay almost $949 million in damages and penalties after a jury in April found the company liable for fraudulently dispensing ...

A bill introduced by Rep. Earl L. "Buddy" Carter would ban PBMs’ use of spread pricing in Medicaid, among other reforms.

While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...

A bill introduced by Rep. Buddy Carter would ban PBMs’ use of spread pricing in Medicaid, among other reforms.

A federal judge in Texas on Friday tossed a lawsuit brought by Humana that challenged the U.S. government's reduction in the ...

Humana (HUM) stock falls as the company loses a lawsuit over its 2025 Medicare Star Ratings cut. Read more here.

A federal judge has tossed out a lawsuit from Humana that attempted to reinstate higher quality ratings to its 2025 Medicare ...

A Texas federal judge dismissed a lawsuit brought by health insurer Humana challenging the U.S. Department of Health and ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

A Las Vegas medical professional pleaded guilty Wednesday to one count of Medicare fraud after fraudulently billing Medicare ...